Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1007/s11060-023-04451-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy
- (2021) Stefanie Krassnig et al. Cancers
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- (2020) Michael Weller et al. Nature Reviews Clinical Oncology
- Eukaryotic initiation factor 4F — sidestepping resistance mechanisms arising from expression heterogeneity
- (2018) Jennifer Chu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
- (2018) Christina L Grek et al. CURRENT OPINION IN PHARMACOLOGY
- Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
- (2017) Doreen William et al. Journal of Translational Medicine
- Vaccine-based immunotherapeutic approaches to gliomas and beyond
- (2017) Michael Weller et al. Nature Reviews Neurology
- Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
- (2017) Nicole Golob-Schwarzl et al. Oncotarget
- Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas
- (2016) Weibing Fan et al. JOURNAL OF NEURO-ONCOLOGY
- peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
- (2016) Elena Martínez-Sáez et al. Cancer Medicine
- PTEN negatively regulates mTORC2 formation and signaling in grade IV glioma via Rictor hyperphosphorylation at Thr1135 and direct the mode of action of an mTORC1/2 inhibitor
- (2016) K Bhattacharya et al. Oncogenesis
- RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells
- (2015) Mingliang Ren et al. Chemical Biology & Drug Design
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells
- (2015) JINMIN HAO et al. Oncology Letters
- Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models
- (2015) Estelle Daudigeos-Dubus et al. PLoS One
- Int6/eIF3e Is Essential for Proliferation and Survival of Human Glioblastoma Cells
- (2014) Julie Sesen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
- (2014) N Robichaud et al. ONCOGENE
- Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management
- (2013) Yongzhi Wang et al. CANCER LETTERS
- Eukaryotic translation initiation factors in cancer development and progression
- (2013) Rita Spilka et al. CANCER LETTERS
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
- (2013) Arshawn Sami et al. TUMOR BIOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells
- (2012) Hong Liang et al. NEUROLOGICAL SCIENCES
- Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies
- (2012) Michael Preukschas et al. PLoS One
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
- (2009) Nahum Sonenberg et al. CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now